A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men (TRAVERSE)

NCT03518034 PHASE4 COMPLETED Results posted

This is a double-blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with pre-existing cardiovascular disease (CVD) or increased risk for CVD.

Details

Lead sponsor	AbbVie
Phase	PHASE4
Status	COMPLETED
Enrolment	5246
Start date	Thu May 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Jan 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hypogonadism
• Cardiovascular Diseases

Interventions

• AndroGel®
• Placebo

Countries

Puerto Rico, United States